Minerva Neurosciences, Inc: Minerva Neurosciences Reports Fourth Quarter 2021 Financial Results and Business Updates
WALTHAM, Mass., March 01, 2022 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV) a clinical-stage biopharmaceutical company focused on the development of innovative therapies to treat central